Quadralynx provides voice dosimeters for speech and voice improvement.
Quadralynx provides wearable biometric devices for adults with motor speech disorders, especially those with volume control issues due to Parkinson’s disease and related neurological disorders. Their device alerts the user via a vibration of a pathological voice state.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 8, 2021 | Grant | $255.63K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |